College Hill wins new brief with Nanobiotix

College Hill has been handed a global brief by nanomedicine firm Nanobiotix, which is looking to raise its profile following the company's public listing.

The agency, which is part of the College Group, will be tasked with handling global and financial corporate PR work on behalf of the company, offering counsel and ongoing support to help Nanobiotix spread its message to audiences worldwide, reports PRWeek.

It is the first PR firm to be appointed to the account on a retained basis and will be aiming to increase awareness of Nanobiotix's services beyond its native France.

Nanobiotix develops new treatments for cancer through innovative nano-particle technology and has been listed as a public company since October 2012.

Melanie Toyne-Sewell, the partner at College Hill who is leading the account, said: "Specifically, our remit is to position Nanobiotix as pioneers in nanomedicine-enabled radiotherapy for more effective cancer treatment."

This comes after the agency recently appointed Veronica Sellar as a new partner for its life sciences team.